Patrick Trojer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TRIANA Biomedicines, Inc. (TRIANA), an innovative biopharmaceutical company focused on advancing a target-first and rational molecular glue discovery platform to address difficult to drug disease targets, today announced that Dr. Patrick Trojer, President and Chief Executive Officer, will present at the UBS Biotechnology Private Company Virtual Symposium on Wednesday September 20, 2023 at 3:30 PM ET.

The stock price of UBS Group AG (NYSE: UBS) has plunged by -0.08 when compared to previous closing price of 26.02, but the company has seen a 1.48% gain in its stock price over the last five trading sessions. Accesswire reported 2023-09-18 that LEXINGTON, MA / ACCESSWIRE / September 18, 2023 / TRIAN

BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America. 

Robert A. Copeland, PhD and Adrian M. Senderowicz, MD join Scientific Advisory BoardWALTHAM, MA / ACCESSWIRE / June 23, 2022 / TRIANA Biomedicines, Inc. (TRIANA), a leading biopharmaceutical company focused

Press release content from Accesswire. The AP news staff was not involved in its creation.